TD PRIVATE CLIENT WEALTH LLC
Position in LKFT — Lakefront Biotherapeutics NV
CIK 1551017
NEW YORK, NY
Position in LKFT
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$1,618
-$212 QoQ
Shares Held
54
-11.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#66
of 78 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LKFT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026TD PRIVATE CLIENT WEALTH LLC holds $2,695,967 across 45 Biotechnology names. LKFT ranks #28 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,440 | $731,270 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
2,863 | $689,897 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,361 | $676,049 | |
| 4 | GMAB |
Genmab A/S
|
4,376 | $120,208 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
150 | $93,531 | |
| 6 | MRNA |
Moderna, Inc.
|
1,305 | $91,389 | |
| 7 | INSM |
INSMED Inc
|
517 | $55,122 | |
| 8 | ARGX |
Argenx SE
|
28 | $25,977 |
All Filings in LKFT
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,618 | 54 | Shares | Defined | 2026-08-04 | |
| 2026-03-31 | $1,830 | 61 | Shares | Defined | 2026-04-27 | |
| 2025-12-31 | $784 | 24 | Shares | Defined | 2026-02-05 | |
| 2025-09-30 | $831 | 24 | Shares | Defined | 2025-10-27 | |
| 2025-06-30 | $671 | 24 | Shares | Defined | 2025-07-15 | |
| No filing history on record for this holder in this stock. | ||||||